Related references
Note: Only part of the references are listed.Stopping Seizures Early and the Surgical Epilepsy Trial That Stopped Even Earlier
Donald L. Schomer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Complement and cytokine based therapeutic strategies in myasthenia gravis
Erdem Tuezuen et al.
JOURNAL OF AUTOIMMUNITY (2011)
MG-ADL: STILL A RELEVANT OUTCOME MEASURE
Srikanth Muppidi et al.
MUSCLE & NERVE (2011)
Current and emerging therapies for the treatment of myasthenia gravis
Renato Mantegazza et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2011)
Responder Analyses-A PhRMA Position Paper
Tom Uryniak et al.
STATISTICS IN BIOPHARMACEUTICAL RESEARCH (2011)
RITUXIMAB IN THE MANAGEMENT OF REFRACTORY MYASTHENIA GRAVIS
Nazlee Zebardast et al.
MUSCLE & NERVE (2010)
CORRELATION OF C3 LEVEL WITH SEVERITY OF GENERALIZED MYASTHENIA GRAVIS
Aidong Liu et al.
MUSCLE & NERVE (2009)
Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals
A. Alshekhlee et al.
NEUROLOGY (2009)
Lifetime course of myasthenia gravis
David Grob et al.
MUSCLE & NERVE (2008)
Current and future standards in treatment of myasthenia gravis
Ralf Gold et al.
NEUROTHERAPEUTICS (2008)
Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria
Russell P. Rother et al.
NATURE BIOTECHNOLOGY (2007)
Therapeutic options in autoimmune myasthenia gravis
Mario Garcia-Carrasco et al.
AUTOIMMUNITY REVIEWS (2007)
Myasthenia gravis: past, present, and future
Bianca M. Conti-Fine et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Complement membrane attack is required for endplate damage and clinical disease in passive experimental myasthenia gravis in Lewis rats
J. Chamberlain-Banoub et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2006)
Does this patient have myashtenia gravis?
K Scherer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
The role of complement in myasthenia gravis: serological evidence of complement consumption in vivo
F Romi et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Clinical evaluation and management of myasthenia gravis
JC Keesey
MUSCLE & NERVE (2004)
Ventilatory care in myasthenia gravis crisis: Assessing the baseline adverse event rate
PN Varelas et al.
CRITICAL CARE MEDICINE (2002)
How to handle myasthenic crisis - Essential steps in patient care
RS Bedlack et al.
POSTGRADUATE MEDICINE (2000)